AHTR — American Healthcare REIT Income Statement
0.000.00%
Last trade - 00:00
- $2.17bn
- $4.30bn
- $1.87bn
- 54
- 81
- 26
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,223 | 1,244 | 1,282 | 1,643 | 1,867 |
Cost of Revenue | |||||
Gross Profit | 255 | 251 | 252 | 362 | 364 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,143 | 1,163 | 1,264 | 1,640 | 1,820 |
Operating Profit | 80.4 | 81.1 | 17.9 | 3.18 | 46.2 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.672 | 5.79 | -52.3 | -72.8 | -76.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.852 | 8.86 | -53.3 | -73.4 | -76.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -4.96 | 2.16 | -47.8 | -81.3 | -71.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.96 | 2.16 | -47.8 | -81.3 | -71.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.077 | 0.13 | -0.534 | -0.424 | -1.1 |